Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celia Requena

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Cancers|October 23, 2021
Mutational Characterization of Cutaneous Melanoma Supports Divergent Pathways Model for Melanoma DevelopmentDavid Millán-Esteban, María Peña-Chilet, Zaida García-Casado, et al.
Scientific Reports|May 16, 2020
Coding and noncoding somatic mutations in candidate genes in basal cell carcinomaMaria Giovanna Maturo, Sivaramakrishna Rachakonda, Barbara Heidenreich, et al.
Dermatology and Therapy|June 15, 2020
Intralesional Methotrexate for the Treatment of Advanced Keratinocytic Tumors: A Multi-Center Retrospective StudyGiulio Gualdi, Simone Caravello, Fabiano Frasci, et al.
International Journal of Cancer|March 27, 2015
High nevus counts confer a favorable prognosis in melanoma patientsSimone Ribero, John R Davies, Celia Requena, et al.
European Journal of Cancer (Oxford, England : 1990)|January 8, 2021
Differences in cutaneous melanoma survival between the 7th and 8th edition of the American Joint Committee on Cancer (AJCC). A multicentric population-based studyAlicia Barreiro-Capurro, Juan J Andrés-Lencina, Sebastian Podlipnik, et al.
Oncotarget|September 30, 2015
Frequent DPH3 promoter mutations in skin cancersEvgeniya Denisova, Barbara Heidenreich, Eduardo Nagore, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 14, 2020
Corrigendum to "Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma" [Eur J Surg Oncol 46 2 (2019) 263-271]Aram Boada, Antonio Tejera-Vaquerizo, Simone Ribero, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 10, 2019
Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanomaAram Boada, Antonio Tejera-Vaquerizo, Simone Ribero, et al.
Dermatology (Basel, Switzerland)|November 2, 2023
Molecular Profile of Subungual Melanoma: A MelaNostrum Consortium Study of 68 Cases Reporting BRAF, NRAS, KIT, and TERT Promoter StatusDavid Millan-Esteban, Zaida García-Casado, Anna Macià, et al.
International Journal of Cancer|September 30, 2017
Sentinel lymph node biopsy versus observation in thick melanoma: A multicenter propensity score matching studyAram Boada, Antonio Tejera-Vaquerizo, Simone Ribero, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Cancers|October 23, 2021
Mutational Characterization of Cutaneous Melanoma Supports Divergent Pathways Model for Melanoma DevelopmentDavid Millán-Esteban, María Peña-Chilet, Zaida García-Casado, et al.
Scientific Reports|May 16, 2020
Coding and noncoding somatic mutations in candidate genes in basal cell carcinomaMaria Giovanna Maturo, Sivaramakrishna Rachakonda, Barbara Heidenreich, et al.
Dermatology and Therapy|June 15, 2020
Intralesional Methotrexate for the Treatment of Advanced Keratinocytic Tumors: A Multi-Center Retrospective StudyGiulio Gualdi, Simone Caravello, Fabiano Frasci, et al.
International Journal of Cancer|March 27, 2015
High nevus counts confer a favorable prognosis in melanoma patientsSimone Ribero, John R Davies, Celia Requena, et al.
European Journal of Cancer (Oxford, England : 1990)|January 8, 2021
Differences in cutaneous melanoma survival between the 7th and 8th edition of the American Joint Committee on Cancer (AJCC). A multicentric population-based studyAlicia Barreiro-Capurro, Juan J Andrés-Lencina, Sebastian Podlipnik, et al.
Oncotarget|September 30, 2015
Frequent DPH3 promoter mutations in skin cancersEvgeniya Denisova, Barbara Heidenreich, Eduardo Nagore, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 14, 2020
Corrigendum to "Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma" [Eur J Surg Oncol 46 2 (2019) 263-271]Aram Boada, Antonio Tejera-Vaquerizo, Simone Ribero, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 10, 2019
Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanomaAram Boada, Antonio Tejera-Vaquerizo, Simone Ribero, et al.
Dermatology (Basel, Switzerland)|November 2, 2023
Molecular Profile of Subungual Melanoma: A MelaNostrum Consortium Study of 68 Cases Reporting BRAF, NRAS, KIT, and TERT Promoter StatusDavid Millan-Esteban, Zaida García-Casado, Anna Macià, et al.
International Journal of Cancer|September 30, 2017
Sentinel lymph node biopsy versus observation in thick melanoma: A multicenter propensity score matching studyAram Boada, Antonio Tejera-Vaquerizo, Simone Ribero, et al.
Pageof 15